20 July 2022
Due to the changing nature of the COVID-19 pandemic and contributing factors, the Global Fund will be supporting implementing countries to urgently reinvest COVID-19 Response Mechanism (C19RM) funds, where the initial intent of these investments no longer responds to current and projected national needs and priorities.
The reinvestment process is also an unprecedented opportunity to align C19RM funding with the priorities of the 2023-2025 funding cycle, particularly strengthening health and community systems and preparedness for future pandemics.
For implementing countries to be able to use C19RM funds by the 31 December 2023 deadline, reinvestment decisions need to be approved by Country Teams by 31 August 2022 to allow for health products orders lead-times and complete key implementation milestones.
During the reinvestment dialogue, implementing countries will be required to identify new and/or update their unfunded demand to be ready for a C19RM Portfolio Optimization wave in September 2022. Portfolio Optimization is a Global Fund financing process that swiftly provides countries with additional funds to enable the scale-up of existing interventions within the scope of C19RM.
To streamline reinvestment efforts with C19RM Portfolio Optimization, registration of unfunded demand should be done by 2 September 2022.
The Annex 6: Guidance for C19RM Reinvestment Planning provides technical and programmatic orientated materials.
Information sessions for CCMs and PRs will take place on 25 and 26 July, and 4 and 5 August in English and French. See the operational update [ download in English | Español | Français ] for more information.